Blueport Acquisition
BPACR · NASDAQ
About BPACR
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Nov 12, 2025
- Sector
- N/A
- Industry
- N/A
- Website
- blueportacquisition.com
BPACR key statistics
- Market cap
- 75.62M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 8
- Volume
- 1.01K
- Open price
- $0.112
- High today
- $0.12
- Low today
- $0.12
- 52 Week high
- $0.99
- 52 Week low
- $0.10
Blueport Acquisition (BPACR) at a glance
As of Oct 28, 2026, Blueport Acquisition (BPACR) shares are priced at $0.12, giving the company a market cap of 75.62M and a price-to-earnings ratio of 0.00.
Volume so far is 1.01K shares, above the average of 8 shares a day.
Over the past year Blueport Acquisition has ranged from $0.10 to $0.99, and now sits 2% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.